Resource Centre
32 results
Antibiotic-mediated selection of randomly mutagenised and cytokine-expressing oncolytic viruses
- Biopharma
- Cancer research
- Virus
- MinION
November 28 2024
Enhancing cell and gene therapy success with multi-omic sequencing
- Biopharma
- AAV
- Webinar
- Plasmid
November 15 2024
An optimised protocol for quality control of gene therapy vectors using nanopore direct RNA sequencing
- Biopharma
- Direct analysis
- RNA
- Virus
- Microbiology
- GridION
October 28 2024
Using nanopore sequencing for mRNA vaccine quality control: a journey from R&D to GMP
- Biopharma
- Bioinformatics
- GridION
- Transcriptomics
September 18 2024
The potential of therapeutic mRNA — and how to measure it
- Biopharma
- Cancer research
- Clinical research
- MinION
- GridION
- Q-Line
- Targeted
September 18 2024
The art of GMP in the world of NGS: trials, tribulations, and a whole lot of acronyms — a success story
- Biopharma
- Clinical research
- Bioinformatics
- Human genomics
- GridION
- Structural variation
- Targeted
September 18 2024
Precision cell engineering enabled through nanopore sequencing
- Biopharma
- Bioinformatics
- P2
- Assembly
- Epigenetics
- Gene expression
- Whole genome
September 18 2024
NESSI-Seq: novel cfDNA methylation assays for biomarker discovery and precision medicine
- Biopharma
- Cancer research
- Bioinformatics
- Human genomics
- PromethION
- Epigenetics
- SNVs
- Phasing
- Structural variation
- Targeted
- Whole genome
September 18 2024
Nanopore sequencing and functional screening of AAV genomes for optimal production and function
- Biopharma
- Clinical research
- Bioinformatics
- MinION
- Single cell
- Structural variation
September 18 2024
Implementation of sequencing in a regulated environment
- Biopharma
- Infectious disease
- Microbiology
- MinION
- GridION
- P2
- GridION Q
- Assembly
- Metagenomics
- Targeted
- Whole genome
September 18 2024
From plasmids to mRNA, comprehensive nanopore QC tests for biomanufacturing
- Biopharma
- GridION
- Assembly
- Gene expression
- Structural variation
- Transcriptomics
September 18 2024
Antibody discovery through post-vaccination single-cell transcriptomics and haplotype-resolved germline sequencing
- Biopharma
- Clinical research
- Bioinformatics
- Human genomics
- Infectious disease
- P2
- PromethION
- EPI2ME
- Assembly
- Epigenetics
- Gene expression
- Single cell
- SNVs
- Phasing
- Structural variation
- Transcriptomics
- Whole genome
September 18 2024
Adventitious agent screening by long-read NGS
- Biopharma
- Microbiology
- GridION
- Metagenomics
September 18 2024
A sensitive sample preparation pipeline for adventitious virus detection using nanopore sequencing
- Biopharma
- Bioinformatics
- GridION
- Metagenomics
- Targeted
September 18 2024
Smarter genomics for streamlined answers — ElysION, sample-to-answer nanopore sequencing device
- Biopharma
- Infectious disease
- Microbiology
- TurBOT
- Metagenomics
September 17 2024
Decoding the spliced HIV-1 transcriptome with accurate long-read RNA sequencing
- Biopharma
- Bioinformatics
- Human genomics
- Infectious disease
- MinION
- P2
- Gene expression
- SNVs
- Phasing
- Targeted
- Transcriptomics
September 17 2024
Characterisation of a marine bacteria through a novel metabologenomics approach
- Biopharma
- Microbiology
- Whole genome
- MinION
- Guppy
August 11 2024
A nanopore sequencing-based pharmacogenomic panel to personalise tuberculosis drug dosing
- Biopharma
- MinION
- Targeted
- Clinical research
- Phasing
- Human genomics
- Long-read
June 15 2024
Quality control of gene therapy vectors using nanopore direct RNA sequencing
- Biopharma
- Bioinformatics
- Isoforms
- Transcriptomics
- London Calling
May 24 2024
Pathogen safety in biopharma: sequencing to come
- Biopharma
- London Calling
- Infectious disease
- GridION
- MinION
- MinION Mk1B
May 24 2024